New York A 8130: Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine

Status: HELD FOR CONSIDERATION IN HEALTH (as of 2024-05-14)

State: New York · Session: 2023-2024 · Bill: A 8130

Sponsors: Joe DeStefano, Anil Beephan Jr., Brian D. Miller, Brian Maher, David DiPietro, Eric Brown, Jake Ryan Blumencranz, Jeff Gallahan, Jodi Giglio, Joe Angelino, John K. Mikulin, John Lemondes, Keith Brown, Kenneth Blankenbush, Lester Chang, Marjorie Byrnes, Matthew Simpson, Michael Durso, Michael Novakhov, Scott Gray, Scott H. Bendett, Stephen Hawley

View New York A 8130 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.